| Literature DB >> 30072092 |
Carlotta Giorgi1, Saverio Marchi1, Ines C M Simoes2, Ziyu Ren3, Giampaolo Morciano4, Mariasole Perrone1, Paulina Patalas-Krawczyk2, Sabine Borchard5, Paulina Jędrak6, Karolina Pierzynowska6, Jędrzej Szymański2, David Q Wang7, Piero Portincasa8, Grzegorz Węgrzyn6, Hans Zischka9, Pawel Dobrzyn2, Massimo Bonora10, Jerzy Duszynski2, Alessandro Rimessi1, Agnieszka Karkucinska-Wieckowska11, Agnieszka Dobrzyn12, Gyorgy Szabadkai13, Barbara Zavan14, Paulo J Oliveira15, Vilma A Sardao15, Paolo Pinton16, Mariusz R Wieckowski2.
Abstract
Aging has been linked to several degenerative processes that, through the accumulation of molecular and cellular damage, can progressively lead to cell dysfunction and organ failure. Human aging is linked with a higher risk for individuals to develop cancer, neurodegenerative, cardiovascular, and metabolic disorders. The understanding of the molecular basis of aging and associated diseases has been one major challenge of scientific research over the last decades. Mitochondria, the center of oxidative metabolism and principal site of reactive oxygen species (ROS) production, are crucial both in health and in pathogenesis of many diseases. Redox signaling is important for the modulation of cell functions and several studies indicate a dual role for ROS in cell physiology. In fact, high concentrations of ROS are pathogenic and can cause severe damage to cell and organelle membranes, DNA, and proteins. On the other hand, moderate amounts of ROS are essential for the maintenance of several biological processes, including gene expression. In this review, we provide an update regarding the key roles of ROS-mitochondria cross talk in different fundamental physiological or pathological situations accompanying aging and highlighting that mitochondrial ROS may be a decisive target in clinical practice.Entities:
Keywords: Age-related neurodegenerative disorders; Aging; Anti-ROS intervention; Antioxidant defense; Mitochondria; Mitochondrial dysfunction–related pathologies; ROS
Mesh:
Substances:
Year: 2018 PMID: 30072092 PMCID: PMC8127332 DOI: 10.1016/bs.ircmb.2018.05.006
Source DB: PubMed Journal: Int Rev Cell Mol Biol ISSN: 1937-6448 Impact factor: 6.813